NovaBridge Biosciences (NBP) Interest & Investment Income (2019 - 2025)

NovaBridge Biosciences (NBP) has 5 years of Interest & Investment Income data on file, last reported at $1.8 million in Q4 2025.

• Quarterly Interest & Investment Income fell 18.43% year-over-year to $1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.6 million (up 1.67% YoY) and the FY2025 annual result came in at $7.6 million, up 1.67% from the prior year.
• Interest & Investment Income fell to $1.8 million in Q4 2025 per NBP's latest filing, from $2.1 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $2.9 million in Q2 2023 and bottomed at $709000.0 in Q1 2024.
• The 3-year median for Interest & Investment Income is $2.1 million (2025), against an average of $2.1 million.
• The widest annual swing landed in 2024, when Interest & Investment Income declined 26.24%; it then jumped 164.03% in 2025.
• Tracing NBP's Interest & Investment Income over 3 years: stood at $2.3 million in 2023, then retreated by 4.69% to $2.2 million in 2024, then slipped by 18.43% to $1.8 million in 2025.
• Per Business Quant, the three latest NBP Interest & Investment Income figures stand at $1.8 million (Q4 2025), $2.1 million (Q3 2025), and $1.8 million (Q2 2025).

Peer Comparison